1. Home
  2. PCT vs HRMY Comparison

PCT vs HRMY Comparison

Compare PCT & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PureCycle Technologies Inc.

PCT

PureCycle Technologies Inc.

HOLD

Current Price

$8.92

Market Cap

1.8B

Sector

Utilities

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$37.65

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCT
HRMY
Founded
2015
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PCT
HRMY
Price
$8.92
$37.65
Analyst Decision
Buy
Strong Buy
Analyst Count
3
9
Target Price
$13.67
$51.33
AVG Volume (30 Days)
4.0M
779.7K
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.44
EPS
N/A
3.17
Revenue
$5,660,000.00
$825,944,000.00
Revenue This Year
N/A
$23.11
Revenue Next Year
$689.83
$16.15
P/E Ratio
N/A
$11.94
Revenue Growth
N/A
21.13
52 Week Low
$5.40
$25.52
52 Week High
$17.37
$40.93

Technical Indicators

Market Signals
Indicator
PCT
HRMY
Relative Strength Index (RSI) 48.04 56.93
Support Level $7.43 $37.12
Resistance Level $9.71 $40.87
Average True Range (ATR) 0.63 1.36
MACD 0.09 -0.32
Stochastic Oscillator 64.58 40.59

Price Performance

Historical Comparison
PCT
HRMY

About PCT PureCycle Technologies Inc.

PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: